Researchers are reporting two promising approaches to counteract malaria's growing drug resistance. Switzerland-based Novartis has released results for a new experimental drug called GanLum.

A single dose of a four-drug combination therapy for uncomplicated malaria was just as effective as the multi-day standard of ...

Global vaccine alliance Gavi and its partner Unicef will pay 25% less for a new malaria vaccine made by the Serum Institute ...

A new study reveals how climate change could expand malaria mosquito habitats, putting millions at risk. Discover which ...

Edson Mwebesa, Fellow at the Wits-based Sub-Saharan Africa Advanced Consortium for Biostatistics (SSACAB), knows children who ...

One of the world’s biggest funders of the fight against HIV, tuberculosis and malaria faces reduced funding for life-saving ...

The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis ...

Ines’ research takes a multidisciplinary approach to understand the spread, evolution, and molecular interaction of the ...

With victims numbering in the millions, malaria is an infectious disease caused by the bite of a mosquito carrying the ...

For the past quarter-century, the gold standard malaria treatment has been artemisinin combination therapies (ACTs). Yet ...

Patronus Biotech receives grant to evaluate a novel malaria vaccine and adjuvant to support affordable access and use in ...

Delhi recorded its highest November malaria cases in four years even as dengue numbers fell sharply. Know symptoms, reasons, ...